Adjuvanted recombinant zoster vaccine is effective against herpes zoster ophthalmicus, and is associated with lower risk of acute myocardial infarction and stroke in adults aged ≥50 years

Journal:

Clinical Infectious Diseases

Published:

2025-08-09

DOI:

10.1093/cid/ciaf440

Affiliations:

4

Authors:

17

Go to article

Institutions	Authors	Share
Kaiser Permanente, United States of America (USA)	11.500000 11.500000	0.68
GlaxoSmithKline USA, United States of America (USA)	4.000000	0.24
Hawaii Permanente Medical Group, United States of America (USA)	1.000000	0.06
Kaiser Permanente Bernard J. Tyson School of Medicine, United States of America (USA)	0.500000	0.03

Interested in Clinical Sciences?